News

The drive is supported by an additional £56 million funding from Cancer Research UK.

In 2017, NICE recommended Holoclar as an option for adults with moderate-to-severe LSCD after eye burns

Pfizer’s Xeljanz could potentially increase the risk of blood clots.

AbbVie’s blockbuster Humira still holds the crown for being the world’s best selling drug.

The results represent a “historic” moment in cystic fibrosis care.

The pharma giant reported sales of £9.4 billion for the third quarter, with HIV drug sales also supporting profits.

Biogen is set to pay Alkermes $150 million in connection with the approval.

The findings also show that deliveries for women under 20 have more than halved in a decade.

The decision marks the first biologic approved in the European Union for severe chronic rhinosinusitis.

The project will help to accelerate and support the development of nurses and midwives looking to develop a career leading research.

The decision was based on a “low probability to meet main goal of study.”

The decision comes as both drugs, used primarily to treat schizophrenia and bipolar disorder, have lost their compound patent protection in the areas.

The drug was initially given a NICE nod back in 2016, and cleared by the European regulators back in 2011.

In an initial pilot that used Facebook to promote breast screening, one area saw a 12.9% increase in the take up of screening services.